ARFIP2
Arfaptin-2
Also known as: ARFP2_HUMAN, POR1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P53365
- Gene
- ARFIP2
- Ensembl
- ENSG00000132254
- Chromosome
- 11
- Canonical length
- 341 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Golgi apparatus
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables several functions, including GTP-dependent protein binding activity; membrane curvature sensor activity; and phosphatidylinositol-4-phosphate binding activity. Involved in actin cytoskeleton organization; mitophagy; and protein localization to phagophore assembly site. Located in several cellular components, including nucleolus; ruffle; and trans-Golgi network membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
341 residues, UniProt reviewed canonical sequence.
>P53365|ARFIP2
1 MTDGILGKAA TMEIPIHGNG EARQLPEDDG LEQDLQQVMV SGPNLNETSI VSGGYGGSGD
61 GLIPTGSGRH PSHSTTPSGP GDEVARGIAG EKFDIVKKWG INTYKCTKQL LSERFGRGSR
121 TVDLELELQI ELLRETKRKY ESVLQLGRAL TAHLYSLLQT QHALGDAFAD LSQKSPELQE
181 EFGYNAETQK LLCKNGETLL GAVNFFVSSI NTLVTKTMED TLMTVKQYEA ARLEYDAYRT
241 DLEELSLGPR DAGTRGRLES AQATFQAHRD KYEKLRGDVA IKLKFLEENK IKVMHKQLLL
301 FHNAVSAYFA GNQKQLEQTL QQFNIKLRPP GAEKPSWLEE QLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARFIP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 54 nTPM
Expression across tissuesHPA
Tissue
- salivary gland: 54 nTPM
- choroid plexus: 54 nTPM
- pancreas: 54 nTPM
- prostate: 49 nTPM
- breast: 48 nTPM
- stomach: 48 nTPM
Single-cell type
- syncytiotrophoblasts: 138 nCPM
- goblet cells: 124 nCPM
- esophageal apical cells: 114 nCPM
- cytotrophoblasts: 92 nCPM
- esophageal suprabasal cells: 86 nCPM
- extravillous trophoblasts: 83 nCPM
Immune cell
- myeloid DC: 21 nTPM
- NK-cell: 21 nTPM
- T-reg: 19 nTPM
- gdT-cell: 18 nTPM
- MAIT T-cell: 18 nTPM
- naive CD8 T-cell: 17 nTPM
Brain region
- choroid plexus: 37 nTPM
- cerebral cortex: 31 nTPM
- white matter: 29 nTPM
- cerebellum: 29 nTPM
- thalamus: 28 nTPM
- pons: 28 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.43
- gnomAD pLI
- 0.77
- gnomAD missense Z
- 1.69
- DepMap mean gene effect
- 0.17
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin cytoskeleton organization
- intracellular protein transport
- lamellipodium assembly
- mitophagy
- protein localization to phagophore assembly site
- regulation of Arp2/3 complex-mediated actin nucleation
- ruffle organization
- small GTPase-mediated signal transduction
Molecular functions
- cadherin binding
- GTP binding
- GTP-dependent protein binding
- identical protein binding
- membrane curvature sensor activity
- phosphatidylinositol-4-phosphate binding
- phospholipid binding
- protein domain specific binding
- small GTPase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARFIP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARFIP2 as an antibody target. Whether an autoantibody or antibody against ARFIP2 could matter depends on whether native ARFIP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARFIP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ARFIP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...